End-to-End Specialty Oral Manufacturing

IDT Australia provides turnkey cGMP contract manufacturing for finished dose oral products, supporting clients from pre-clinical studies, through Phase I–III clinical trials, to commercial supply. Our expertise spans solid dose forms (tablets and capsules) and non-sterile liquid orals, including white-label, client-labelled, and clinical S8 & S9 products for specialist supply. Finished products can incorporate APIs manufactured onsite or via tech transfer.

Speciality Orals Capabilities

Hard Shell Capsule Manufacturing

  • Up to ~100,000 capsules per hour
  • Suitable for a range of formulations, including cytotoxic and non-cytotoxic products

Tablet Manufacturing

  • Production capacity of up to ~100,000 tablets per hour
  • Supports various tablet formats (immediate-release, modified-release, coated, etc.)

Liquid Oral Manufacturing

  • Bottling formats: 30 mL - 500 mL
  • Output: Up to 3,000 (50mL) bottles per day
  • Ideal for suspensions, solutions, and specialty oral liquids

Psychedelics & Medicinal Cannabis

One of IDT Australia’s specialist therapeutic areas is neuroscience, mental health, and CNS therapeutics. IDT Australia is a trusted partner in Australia for the development, synthesis, and formulation of controlled substances. With extensive experience in medicinal cannabis processing and formulation, we support SAS and specialist supply. We have applied this expertise to psychedelic products, ensuring full compliance under Schedule 8 and Schedule 9 licensing.

round white pills on hand specialty orals manufacturing

Why Partner with IDT Australia for Specialty Orals

Partnering with IDT Australia ensures your oral dosage products are developed and manufactured to the highest cGMP standards, with a focus on quality, compliance, and efficiency. Our clients benefit from:

  • Support at all stages of specialty oral development and manufacturing.
  • Flexible formulation capabilities: We manufacture solid dose orals (tablets, capsules, orally dissolving tablets) and non-sterile liquids, including the ability to handle both wet granulation and dry granulation processes for optimised tablet performance.
  • Efficient scale-up and manufacturing: High-capacity production for tablets (up to 100,000/hr) and capsules (up to 100,000/hr), as well as liquid bottling (up to 3,000 bottles/day), helping accelerate your time to market.

Contact IDT Australia

If you’re looking for quality, turnkey cGMP contract manufacturing services, get in touch with us today to speak with one of our API specialists.

Talk to an expert